Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PMA (premarket approval) supplement for CardioVascular Dynamics' coronary catheter:

This article was originally published in Clinica

Executive Summary

CardioVascular Dynamics has received a premarket approval supplement for its Guardian coronary catheter, part of a range of catheters developed using the company's Focus technology. It allows most of the dilation force during a balloon angioplasty procedure to be focused more directly to the lesion site. The Guardian catheter is made from a softer, polyethylene-blend material which enhances movement of the guidewire. Its distal tip has been elongated to hug the guidewire, allowing the catheter to reach more distal parts of the anatomy. The company expects full marketing of the product in August.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel